OTCMKTS:BLUSF BELLUS Health (BLUSF) Stock Forecast, Price & News Notice: This company has been marked as potentially delisted and may not be actively trading. Add Compare Share Share Today's Range$14.60▼$14.6750-Day Range$6.46▼$14.5152-Week Range$0.49▼$2.60Volume542,701 shsAverage Volume39,610 shsMarket Capitalization$2.33 billionP/E RatioN/ADividend YieldN/APrice TargetN/A ProfileProfileHeadlinesProfileHeadlines About BELLUS Health (OTCMKTS:BLUSF) StockBELLUS Health, Inc. is a biopharmaceutical development company, which engages in the research and development of products that provide health solutions and address critical unmet medical needs. Its products include BLU-5937, KIACTA, AMO-01, and ALZ-801. The company was founded on June 17, 1993 and is headquartered in Laval, Canada.Read More Receive BLUSF Stock News and Ratings via Email Sign-up to receive the latest news and ratings for BELLUS Health and its competitors with MarketBeat's FREE daily newsletter. Email Address BLUSF Stock News HeadlinesMay 12, 2023 | msn.comBELLUS Health: Q1 Earnings InsightsApril 19, 2023 | markets.businessinsider.comWhere BELLUS Health Stands With AnalystsJune 4, 2023 | Behind the Markets (Ad)[BREAKING] New "Living Missile" to Replace Nuclear MissilesCBS News Reports: "It's an entirely new type of weapon." The New York Times Reports: "No existing defense can stop it." And one small company is building them for the Pentagon!April 18, 2023 | msn.comGSK to Buy Bellus for $2 Billion to Gain Cough MedicineApril 5, 2023 | seekingalpha.comBellus Health posts proof-of-concept data for cough candidateApril 5, 2023 | markets.businessinsider.comBELLUS: Phase 1 Study Establishes Proof Of Concept For Developing ER Formulation Of CamlipixantApril 5, 2023 | markets.businessinsider.comBELLUS: Phase 1 Study Establishes Proof Of Concept For Developing ER Formulation Of CamlipixantMarch 29, 2023 | americanbankingnews.comBELLUS Health (OTCMKTS:BLUSF) Hits New 12-Month High at $7.54June 4, 2023 | Legacy Research (Affiliate) (Ad)From -60% Account to Doubling His Money?After helping his readers double their money 13 TIMES in the last year alone… There’s ONE person trader Jeff Clark has NOT been able to help! His 23-year-old son, Grant.November 14, 2022 | benzinga.comBELLUS Health Reports Third Quarter 2022 Financial Results and Business HighlightsNovember 14, 2022 | msn.comBellus Health (BLU) Reports Q3 Loss, Misses Revenue EstimatesOctober 10, 2022 | yahoo.comBELLUS Health to Present Clinical Data from Phase 2b SOOTHE Trial of BLU-5937 at the CHEST Annual MeetingJuly 18, 2022 | benzinga.comBELLUS Health Closes US$153 Million Public Offering of Common Shares in Canada and the United StatesMarch 10, 2022 | gurufocus.comPower Corp of Canada Buys BELLUS Health Inc, Sells Alibaba Group Holding, New Oriental ...February 17, 2022 | gurufocus.comFirst Light Asset Management, LLC Buys AtriCure Inc, Keros Therapeutics Inc, BELLUS Health Inc, ...September 13, 2021 | benzinga.comWhat's Going On With BELLUS Health's Stock Today?September 15, 2020 | seekingalpha.comBELLUS Health Inc (BLU) Investor Presentation - SlideshowJuly 9, 2020 | finance.yahoo.comTrade Alert: The Chairman of the Board Of BELLUS Health Inc. (TSE:BLU), Francesco Bellini, Has Just Spent US$390k Buying 31% More SharesNovember 7, 2019 | www.nasdaq.comBellus Health Inc (BLUSF) Option ChainAugust 15, 2019 | seekingalpha.comBellus Health to reverse split shares 1:3.6June 20, 2019 | seekingalpha.comBELLUS Health (BLUSF) Presents At Raymond James Life Sciences & MedTech Conference - SlideshowJune 7, 2019 | seekingalpha.comBELLUS Health (BLUSF) Presents At Jefferies 2019 Healthcare Conference - SlideshowSee More Headlines BLUSF Company Calendar Last Earnings5/08/2019Today6/04/2023Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeOTCMKTS Industry N/A Sub-IndustryN/A SectorMedical Current SymbolOTCMKTS:BLUSF CUSIPN/A CIKN/A Webwww.bellushealth.com Phone45-0680-4500FaxN/AEmployees10Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)($0.10) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-7,010,000.00 Net Margins-49,910.34% Pretax MarginN/A Return on Equity-48.37% Return on Assets-45.25% Debt Debt-to-Equity RatioN/A Current Ratio13.87 Quick Ratio13.87 Sales & Book Value Annual Sales$30,000.00 Price / Sales77,596.06 Cash FlowN/A Price / Cash FlowN/A Book Value$0.25 per share Price / Book58.52Miscellaneous Outstanding Shares159,117,000Free FloatN/AMarket Cap$2.33 billion OptionableNot Optionable Beta1.55 Key ExecutivesRoberto BelliniPresident, Chief Executive Officer & DirectorFrançois DesjardinsVice President-FinanceDenis GarceauSenior Vice President-Drug DevelopmentTony MatzouranisVice President-Business DevelopmentSébastien RoySecretaryKey CompetitorsHUTCHMEDNASDAQ:HCMAgilitiNYSE:AGTITransMedics GroupNASDAQ:TMDXNuvalentNASDAQ:NUVLLivaNovaNASDAQ:LIVNView All Competitors BLUSF Stock - Frequently Asked Questions How were BELLUS Health's earnings last quarter? BELLUS Health Inc (OTCMKTS:BLUSF) announced its quarterly earnings results on Wednesday, May, 8th. The company reported ($0.02) earnings per share for the quarter, missing the consensus estimate of ($0.01) by $0.01. The company had revenue of $0.01 million for the quarter. BELLUS Health had a negative net margin of 49,910.34% and a negative trailing twelve-month return on equity of 48.37%. What is BELLUS Health's stock symbol? BELLUS Health trades on the OTCMKTS under the ticker symbol "BLUSF." What is BELLUS Health's stock price today? One share of BLUSF stock can currently be purchased for approximately $14.63. How much money does BELLUS Health make? BELLUS Health (OTCMKTS:BLUSF) has a market capitalization of $2.33 billion and generates $30,000.00 in revenue each year. The company earns $-7,010,000.00 in net income (profit) each year or ($0.10) on an earnings per share basis. How can I contact BELLUS Health? BELLUS Health's mailing address is 275 ARMAND-FRAPPIER BLVD., LAVAL A8, H7V 4A7. The official website for the company is www.bellushealth.com. The company can be reached via phone at 45-0680-4500 or via email at fdesjardins@bellushealth.com. This page (OTCMKTS:BLUSF) was last updated on 6/4/2023 by MarketBeat.com Staff Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding BELLUS Health Inc Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.